Kinfo
Fresenius Medical Care AG - Depositary Receipt logo

Fresenius Medical Care AG - Depositary Receipt

FMSNYSEHealthcare·US · USD
$21.06
+0.18 (+0.86%)
Prices as of October 9, 2026 · market closed

Price

Key statistics

Valuation
Market cap11.21B USD
Enterprise value24.57B USD
Trailing P/E10.82
Forward P/E7.02
PEG ratio2.08
Price / sales0.57
Price / book0.78
Profitability
Gross margin0.00%
Operating margin10.77%
Profit margin4.83%
Return on assets3.98%
Return on equity8.52%
Income (TTM)
Revenue21.79B USD
Gross profit5.74B USD
EBITDA3.58B USD
Net income1.05B USD
Diluted EPS$1.94
Rev. growth (YoY)1.40%
Balance sheet
Total cash1.19B USD
Total debt12.31B USD
Debt / equity81.13
Current ratio1.07
Book value / share$26.75
Cash flow (TTM)
Operating cash flow3.17B USD
Levered free cash flow2.27B USD
Shares & price
Shares outstanding532.22M
Float397.12M
Held by institutions9.86%
Beta0.81
50-day MA$23.07
200-day MA$22.99
52-week high$27.54
52-week low$20.02
Dividends
Forward rate
$3.49
Yield
16.56%
Payout ratio
45.01%
Frequency
Annual
Recent payments
  • 2026-05-22$0.87
Earnings (EPS)
DateEst.ActualSurprise2026-08-030.500.56+12.00%2026-05-040.500.46−8.00%2026-02-240.550.72+30.91%2025-11-040.500.55+10.00%2025-08-050.470.46−2.13%
About Fresenius Medical Care AG - Depositary Receipt

Fresenius Medical Care AG - Depositary Receipt is the U.S.-traded American Depositary Receipt for Fresenius Medical Care, a global healthcare company focused on renal care. Fresenius Medical Care provides dialysis products and related services for people with chronic kidney disease, supporting treatment across hospitals, clinics, and home-based care settings. Its business is organized around care delivery and care enablement, combining clinical services with the development, manufacturing, and supply of dialysis equipment, consumables, and associated technologies. The company serves healthcare providers and patients in the United States, Europe, and other international markets, making it an important participant in the kidney care ecosystem. As a depositary receipt, it offers a U.S. listing structure for investors seeking exposure to Fresenius Medical Care’s healthcare operations without directly referencing the underlying foreign share.

Sector
Healthcare
Industry
Medical Care Facilities
CEO
Ms. Helen Giza
Employees
108,165
Headquarters
Bad Homburg, Germany

Frequently asked questions about Fresenius Medical Care AG - Depositary Receipt